Literature DB >> 24114629

Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore.

Hye Jin Yoon1, In Hee Bae, Hyoung Jun Kim, Jung Mi Jang, Yong Su Hur, Hae Kwon Kim, San Hyun Yoon, Won Don Lee, Jin Ho Lim.   

Abstract

PURPOSE: Fertilization failures have occurred repeatedly in reproductive centers after intracytoplasmic sperm injection (ICSI) and artificial oocyte activation (AOA) has been used to prevent it. This study was performed to investigate whether spermatozoan origin influences clinical outcomes of AOA with a calcium ionophore.
METHODS: A total of 185 ICSI cycles with a history of no or low fertilization was included in this retrospective study. The outcomes of AOA after ICSI were compared with ejaculated-normal, ejaculated-oligo-astheno-terato or extracted-testicular spermatozoa.
RESULTS: There were significant differences between the previous standard ICSI cycles and AOA cycles in the rate of fertilization and clinical outcomes among cases with different sperm origins. Thirty-eight healthy babies (20 singles and 18 twins, 29 cycles) were successfully delivered, and no congenital birth defects were observed.
CONCLUSIONS: Most patients with a no or low fertilization history obtained an increased fertilization rate and a positive clinical outcome with AOA regardless of the origin of spermatozoa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24114629      PMCID: PMC3843179          DOI: 10.1007/s10815-013-0110-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  41 in total

1.  A live birth of activated one-day-old unfertilized oocyte for a patient who experienced repeatedly near-total fertilization failure after intracytoplasmic sperm injection.

Authors:  Qun Lu; Xi Chen; Yang Li; Xiao-Hong Zhang; Rong Liang; Yong-Ping Zhao; Li-Hui Wei; Huan Shen
Journal:  Chin Med J (Engl)       Date:  2012-02       Impact factor: 2.628

2.  Assisted oocyte activation is not beneficial for all patients with a suspected oocyte-related activation deficiency.

Authors:  F Vanden Meerschaut; D Nikiforaki; S De Gheselle; V Dullaerts; E Van den Abbeel; J Gerris; B Heindryckx; P De Sutter
Journal:  Hum Reprod       Date:  2012-04-04       Impact factor: 6.918

3.  Successful pregnancy and delivery following intracytoplasmic injection of frozen-thawed nonviable testicular sperm and oocyte activation with calcium ionophore.

Authors:  Ali Ahmady; Essam Michael
Journal:  J Androl       Date:  2006-08-09

4.  Effect of activation with Ca ionophore A23187 and puromycin on the development of human oocytes that failed to fertilize after intracytoplasmic sperm injection.

Authors:  K Nakagawa; S Yamano; N Moride; M Yamashita; M Yoshizawa; T Aono
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

5.  Artificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources.

Authors:  Edson Borges; Daniela Paes de Almeida Ferreira Braga; Tatiana Carvalho de Sousa Bonetti; Assumpto Iaconelli; José Gonçalves Franco
Journal:  Reprod Biomed Online       Date:  2009-01       Impact factor: 3.828

6.  The activity (calcium oscillator?) responsible for human oocyte activation after injection with round spermatids is associated with spermatid nuclei.

Authors:  J Tesarik; C Mendoza; E Greco
Journal:  Fertil Steril       Date:  2000-12       Impact factor: 7.329

7.  Complete globozoospermia associated with PLCζ deficiency treated with calcium ionophore and ICSI results in pregnancy.

Authors:  S L Taylor; S Y Yoon; M S Morshedi; D R Lacey; T Jellerette; R A Fissore; S Oehninger
Journal:  Reprod Biomed Online       Date:  2009-12-28       Impact factor: 3.828

8.  Optimized combined electrical-chemical parthenogenetic activation for in vitro matured bovine oocytes.

Authors:  S M Hosseini; M Hajian; F Moulavi; A H Shahverdi; M H Nasr-Esfahani
Journal:  Anim Reprod Sci       Date:  2007-08-06       Impact factor: 2.145

9.  Successful fertilization and pregnancy after intracytoplasmic sperm injection and oocyte activation with calcium ionophore in a normozoospermic patient with extremely low fertilization rates in intracytoplasmic sperm injection cycles.

Authors:  Hee-Jun Chi; Jung-Jin Koo; Sang-Jin Song; Ji-Youn Lee; Sang-Sik Chang
Journal:  Fertil Steril       Date:  2004-08       Impact factor: 7.329

10.  Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status.

Authors:  Gabor Huszar; Ciler Celik Ozenci; Sevil Cayli; Zoltan Zavaczki; Eleonora Hansch; Lynne Vigue
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

View more
  6 in total

1.  Homozygous missense mutation Arg207Cys in the WEE2 gene causes female infertility and fertilization failure.

Authors:  Xiaoyu Yang; Li Shu; Lingbo Cai; Xueping Sun; Yugui Cui; Jiayin Liu
Journal:  J Assist Reprod Genet       Date:  2019-03-02       Impact factor: 3.412

2.  In vitro Activation of Mouse Oocytes through Intracellular Ca2+ Regulation.

Authors:  Nining Handayani; Budi Wiweko; Sarah Chairani Zakirah; Arief Boediono
Journal:  J Hum Reprod Sci       Date:  2020-07-09

Review 3.  Risk of birth defects in children conceived by artificial oocyte activation and intracytoplasmic sperm injection: a meta-analysis.

Authors:  Rui Long; Meng Wang; Qi Yu Yang; Shi Qiao Hu; Li Xia Zhu; Lei Jin
Journal:  Reprod Biol Endocrinol       Date:  2020-12-11       Impact factor: 5.211

Review 4.  Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application.

Authors:  Junaid Kashir; Durga Ganesh; Celine Jones; Kevin Coward
Journal:  Hum Reprod Open       Date:  2022-02-07

5.  Assisted Oocyte Activation With Calcium Ionophore Improves Pregnancy Outcomes and Offspring Safety in Infertile Patients: A Systematic Review and Meta-Analysis.

Authors:  Yinghua Shan; Huishan Zhao; Dongmei Zhao; Jianhua Wang; Yuanqing Cui; Hongchu Bao
Journal:  Front Physiol       Date:  2022-01-24       Impact factor: 4.566

6.  An effective method for improving outcomes in patients with a fertilization defect.

Authors:  Hye Jin Yoon; Hyung Jun Kim; In Hee Bae; Soo Jin Chae; San Hyun Yoon; Won Don Lee; Jin Ho Lim
Journal:  Clin Exp Reprod Med       Date:  2014-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.